SK

Srivathsan Krishamur Iyer

Director Director DIN 06448471
DIN 06448471 First appointment Nov 2012 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since Nov 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Srivathsan Krishamur Iyer

Data last updated:

Srivathsan Krishamur Iyer has 13 years in corporate governance. Formerly with 1 company, such as Medigraph Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 06448471
Primary Designation Director
First Appointment 25 Nov 2012
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Nov 20121995₹25.90 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Medigraph Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Srivathsan Krishamur Iyer

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srivathsan Krishamur Iyer

Srivathsan Krishamur Iyer has 13 years in corporate governance. Formerly with 1 company, such as Medigraph Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Srivathsan Krishamur Iyer has expertise in General Business.

Srivathsan Krishamur Iyer has 13 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available